Story · Medicine & Biotech
Infant RSV immunity study (IRIS): protocol for a prospective birth cohort in Vancouver, Canada examining how age at respiratory syncytial virus exposure affects how infants respond to the virus immunologically
1 outlet · first reported by BMJ Open 15h ago
Coverage, in order
-
15h agoInfant RSV immunity study (IRIS): protocol for a prospective birth cohort in Vancouver, Canada examining how age at respiratory syncytial virus exposure affects how infants respond to the virus immunologically
STRENGTHS AND LIMITATIONS OF THIS STUDY The prospective birth-cohort design combines active respiratory surveillance, immune phenotyping, longitudinal microbiome studies in the first year, and follow-up to age 3 years. Serial measurements will characterise infant immune developmental stages…
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.